pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 2·1 min read
save

Butterfly expands from handheld ultrasound to chip manufacturing

Jul 2, 2026·read at Endpoints ↗Positive

Butterfly, known for its portable ultrasound device, is shifting focus toward building its own semiconductor business.

The move mirrors Nvidia's evolution from a gaming‑chip maker to a supplier for many industries, and reflects Butterfly's desire to broaden its revenue base.

By creating custom chips, the company aims to lower costs and boost performance of its imaging products, giving it more control over technology development.

If successful, Butterfly could become a broader supplier of health‑tech components, though the transition will require significant execution risk.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “How Butterfly, once known for its handheld ultrasound device, is growing its chip-making business”

read at Endpoints ↗
87 words · retrieved Jul 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Oric Pharmaceuticals, Inc.

related stories

  • 47m agoVerastem makes its stand as a RevMed competitor in pancreatic cancerEndpoints
  • 2h agoUltragenyx's second PRV sale; Biomea's oral GLP-1 data leads to stock slumpEndpoints
  • 4h agoVir makes solid tumor T cell engager deal with GileadEndpoints
  • 5h agoArrowhead’s brain-targeting RNA drug lowers Alzheimer’s protein in early studyEndpoints
  • 5h agoZealand inks up to $1.3B deal for AI-designed obesity treatmentsEndpoints